Search - tctmd.com

Displaying 81 - 100 of 179

Sort: Relevancy | Date

News Daily News

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

Yael L. Maxwell

June 24, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

Even Less-Severe COVID-19 Can Have Long-term CV Effects

Caitlin E. Cox

February 10, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Conference News ACC 2021

New STRENGTH Analysis Revives Omega-3 Debate

Todd Neale

May 20, 2021

News Daily News

Paper Probes Physical Activity Paradox and Perils of ‘Privileged’ Advice

Shelley Wood

April 15, 2021

Advertisement

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

April 2022 News Roundup

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

March 2022 News Roundup

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Even Less-Severe COVID-19 Can Have Long-term CV Effects

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Another Study Links Stopping Statins to MACE in the Elderly

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

OMT Boosts Survival in Revascularized Patients at 10 Years

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

New STRENGTH Analysis Revives Omega-3 Debate

Paper Probes Physical Activity Paradox and Perils of ‘Privileged’ Advice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content